TargetMol Chemicals Inc.

Firmenname:TargetMol Chemicals Inc.

Telefon:-

E-Mail:marketing@targetmol.com

Nationalit?t:China

Produkte insgesamt:19704

40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144

Produktkatalog

ALK/EGFR-IN-1	2730430-08-5
Antileishmanial agent-16	2934738-41-5
Lp-PLA2-IN-16	1865780-73-9	C22H17F5N4O3
IPG7236	2756350-91-9	C23H31N3O3S
PIKfyve-IN-2	2245319-25-7
Lp-PLA2-IN-15	1865796-11-7	C22H17F5N4O3
Bivamelagon	2641595-54-0	C35H53ClN4O4
P2X3 antagonist 38	2545974-71-6
DRI-C25441	2101765-83-5	C31H21N3O6
Lp-PLA2-IN-13	2756855-62-4
SOS1/KRAS-IN-1	2836330-34-6
CXCR4-IN-1	2304750-48-7
TLR7/8 agonist 8	2649170-16-9	C24H30N6O
DGKζ-IN-1	2660218-70-0	C27H25F3N6O2S
Protein kinase inhibitor 5	2278204-94-5	C29H31F2N7O
PCSK9-IN-16	2455424-51-6	C16H20N6O2S3
JAK-IN-28	2445500-22-9
CDK7-IN-22	2173190-60-6	C22H25F3N6
PCSK9-IN-17	2455424-72-1
HPK1 antagonist-1	2628489-56-3	C28H29FN6O2
HDAC ligand-1	34840-28-3	C7H8N2O
Z1078601926	1493256-85-1	C14H19FN2O
PHD2-IN-1	2768219-28-7
SSI-4	1875084-68-6	C19H21ClN4O3
RIP1 kinase inhibitor 6	2428401-62-9
RIP1 kinase inhibitor 5	2428422-17-5	C13H17F2NO2
UPCDC30766	2152623-68-0
RIP1 kinase inhibitor 4	2919836-00-1
BDM91514	2892824-90-5
Lp-PLA2-IN-12	2637485-14-2
Antitubercular agent-39	1357796-08-7
RIP1 kinase inhibitor 7	2428401-23-2
ETAP	2575731-47-2
Antibacterial agent 141	2930013-56-0
JAK-IN-30	2891469-99-9
S-Gem	2169925-98-6	C13H15F2N3O6S2
Bromodomain inhibitor-12 (edisylate)	2010124-27-1
Bromodomain inhibitor-12	2010124-06-6
SUCNR1-IN-1	2711753-52-3
K-80001	242800-40-4
SORT-PGRN interaction inhibitor 3	2691846-87-2	C15H19Cl2NO3
PB131	2924425-63-6
Tubulin polymerization-IN-42	2640220-51-3
MmpL3-IN-2	2944458-65-3
MEK-IN-6 hydrate	2845153-35-5
THRβ receptor agonist-1	2403721-00-4
TNF-α-IN-10	2247720-56-3
ROCK-IN-6	2489328-74-5	C19H19N5O8S
IRE1α kinase-IN-8	1338933-29-1
Antifungal agent 59	2422019-96-1
VMAT2-IN-2 tosylate	2608770-12-1	C27H36F3NO6S
Bivamelagon hydrochloride	2641595-55-1	C35H54Cl2N4O4
KAT modulator-1	1314006-43-3	C20H36O2
DRI-C21041	2101765-78-8	C30H21N3O7S
IRAK4-IN-28	2952532-92-0
Mcl-1 inhibitor 13	2445466-06-6
HIV-1 inhibitor-56	2952530-45-7
ALK2-IN-5	2414149-20-3	C24H32N8O2
STAT6-IN-3	371919-80-1	C32H35IN3O7P
SOS1-IN-16	2930763-85-0
ATR-IN-24	2370889-43-1	C23H26N6O2
MEK-IN-6	2845151-86-0
BET-IN-15	2408994-22-7	C21H18F2N4O3S
A1/A3 AR antagonist 3	2665804-57-7	C22H19N5O3
PAD4-IN-2	2642327-52-2
BBDDL2059	2691174-27-1
Tau protein aggregation-IN-1	916179-45-8	C17H11BrN2O2
SHP2-IN-14	2673400-91-2
Antileishmanial agent-15	2934738-38-0
RET-IN-23	2479961-46-9	C28H28FN11
Antileishmanial agent-17	2934738-40-4
FKBP51F67V-selective antagonist Ligand2	1680228-76-5
DSO-5a	2195411-63-1
FGFR-IN-11	2658488-68-5
IRE1α kinase-IN-9	1338933-30-4
MAT2A-IN-12	631897-75-1	C20H17NO3
PI3Kγ inhibitor 7	2575863-25-9
Enpp-1-IN-17	2289736-54-3	C18H24N4O2
Antiproliferative agent-30	2713553-88-7
Lp-PLA2-IN-14	2756855-66-8
FD2056	2685870-87-3
Antiproliferative agent-34	2910858-34-1
URAT1&XO inhibitor 1	2669726-78-5
Antitumor agent-101	2848632-52-8
URAT1&XO inhibitor 2	1239488-96-0	C14H12BrNO3
TLR8 agonist 6	2616605-55-9	C19H29N7O2
Mosnodenvir	2890688-86-3
SLMP53-2	1826116-38-4	C26H22N2O2
Anticancer agent 147	2241283-11-2
MDM2/XIAP-IN-2	2761969-85-9	C29H32N2O4S
PROTAC α-synuclein degrader 5	2781922-42-5	C39H41N7O10
TLR7/8 agonist 9	2649170-17-0	C20H26N6O
AMPK activator 11	2948304-00-3
SARS-CoV-2-IN-57	1265624-68-7
Antiproliferative agent-32	2925814-05-5
TRK-IN-23	2924344-29-4
BChE-IN-17	2425632-57-9
AMPA receptor modulator-4	2917551-59-6	C11H12ClFN2O2S
Tegeprotafib	2407610-46-0	C13H11FN2O5S

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

TargetMol Chemicals Inc.

Produktkatalog